ASX Company Announcements


The edited text of our announcements are sourced from the Australian Stock Exchange and are delayed by at least 20 minutes. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.

Cellmid does not take any responsibility in respect of any of the edited text sourced from the Australian Stock Exchange

 

 18 Dec 2015 

 Change of Director's Interest Notice - Maria Halasz

 01 Dec 2015

 Key Antibody Patent Granted in Europe

 24 Nov 2015

 Japanese patent granted for use of MK for hair growth

12 Nov 2015

 Results of Annual General Meeting

12 Nov 2015

 AGM Presentation to Shareholders

30 Oct 2015

 Company Secretary Appointment / Resignation

27 Oct 2015

 Appendix 4C - quarterly

12 Oct 2015

 Cellmid 2015 Annual Report to Shareholders

12 Oct 2015 

 Notice of AGM / Proxy Form

28 Sep 2015 

 Announcement Date of AGM

15 Sep 2015 

 Cleansing Statement and Appendix 3B

09 Sep 2015

 Results of EGM

09 Sep 2015 

 EGM Presentation

31 Aug 2015

 Appendix 4G and Corporate Governance Statement

31 Aug 2015 

 Appendix 4E and Preliminary Financial Report

27 Aug 2015

 Cellmid Launching Major Advertising Campaign

13 Aug 2015 

 Change of Director's Interest Notice - Dr Edward Fintan Walton

12 Aug 2015

 Cellmid appoints EAS to support US Strategy

10 Aug 2015

 Notice of Extraordinary General Meeting and Proxy Form

06 Aug 2015

 CDY Newsletter August 2015

05 Aug 2015 

 Cleansing Notice and Appendix 3B

30 Jul 2015

 Appendix 4C - Quarterly

30 Jul 2015 

 Cellmid Capital Raising

28 Jul 2015 

 Trading Halt

23 Jul 2015

 Initial Director's Interest Notice - Dr Fintan Walton

21 Jul 2015

 Cellmid Appoints Dr Fintan Walton as Director

15 Jul 2015 

 Transcript of Investor Conference Call

09 Jul 2015 

 Cellmid Revenue Guidance Upgrade

07 Jul 2015 

 Dr Bryce Vissel to Chair Cellmid's Scientific Advisory Board

01 Jul 2015 

 Initial Director's Interest Notice - B Gordon

01 Jul 2015 

 Final Director's Interest Notice - M Rogers

01 Jul 2015 

 Final Director's Interest Notice - G Kaufman

30 Jun 2015 

 Change of Registry Address

29 Jun 2015 

 US Patent for Anti-Midkine Antibodies Granted

23 Jun 2015

 Cellmid Announces Brain Cancer Program

17 Jun 2015 

 Cellmid Invited to Present at Breakfast @ BIO

15 Jun 2015

 Positive Toxicology Study Results for CAB102

02 Jun 2015 

 Cellmid Signs Agreement with Maywufa

26 May 2015 

 Director Appointment / Resignation

19 May 2015

 Appendix 3B

15 May 2015

 Cellmid Secures $1M Loan Funding

 29 Apr 2015

 Appendix 4C - quarterly

15 Apr 2015 

 Positive Clinical Results for Cellmid Hair Growth Product

13 Apr 2015

 Cellmid to present MK at World Congress of Angiogenesis

31 Mar 2015

 Company Secretary Appointment/Resignation

10 Mar 2015

 Change of Director's Interest Notice

04 Mar 2015

 Broker Meets Biotech Presentation

24 Feb 2015 

 Appendix 4D and Half Year Accounts

11 Feb 2015

 Cellmid Newsletter February Issue

28 Jan 2015

 Appendix 4C - quarterly

21 Jan 2015

 USA Patent Granted for MK Treatment of Heart Failure

12 Jan 2015

 Australian Patent Granted for Use of Midkine for Hair Growth